Let’s work together against superbugs
Pharma industry calls on governments to help tackle antibiotic resistance
More than 80 drug, diagnostics and biotechnology companies have come together to ask governments to move forward, in collaboration with companies, to support investment in the development of antibiotics, diagnostics, vaccines, and other products needed to prevent and treat drug-resistant infections. This is in their opinion necessary to generate dependable and sustainable markets for antibiotics, to allow companies to make the necessary investment in R&D for new antibiotic discovery and development. STAT has a nice news story on this.
In particular, they ask for improved efforts to conserve antibiotics, improve how antibiotics are prescribed, and change health systems that directly reward doctors, pharmacists and veterinarians for prescribing antibiotics in great volumes. To this effect, the U.S. Centers for Disease Control and Prevention (CDC), in cooperation with the American College of Physicians (ACP), has issued new guidelines to prevent doctors from over-prescribing antibiotics, as new research indicates that up to 50 percent of antibiotic prescriptions given out by doctors in an outpatient setting may be inappropriate or even unnecessary.